Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/01/2020 | AMAG PHARMACEUTICALS, INC. | AMAG | Sale | Common Stock | 4.4M | $13.57 | $59.6M | See Footnotes | 10/01/2020 |
08/09/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Purchase | Common Stock | 3.4k | $9.18 | $31.2k | See Footnotes | 08/07/2019 |
08/09/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Purchase | Common Stock | 26.6k | $8.94 | $237.8k | See Footnotes | 08/07/2019 |
08/07/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Purchase | Common Stock | 301k | $7.79 | $2.3M | See Footnotes | 08/07/2019 |
08/07/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Purchase | Common Stock | 4k | $7.58 | $30.3k | See Footnotes | 08/07/2019 |
08/07/2019 | AMAG PHARMACEUTICALS, INC. | AMAG | Purchase | Common Stock | 50k | $7.74 | $387k | See Footnotes | 08/07/2019 |
12/02/2016 | Protalix BioTherapeutics, Inc. | PLX | Sale | Common Stock | 2.5M | $0.32 | $792k | See Footnotes | 12/02/2016 |
02/23/2016 | Cardiovascular Systems Inc | CSII | Purchase | Common Stock | 250k | $7.55 | $1.9M | See Footnotes | 02/23/2016 |
10/19/2015 | Protalix BioTherapeutics, Inc. | PLX | Purchase | Common Stock | 423 | $1.03 | $435.7 | See Footnotes | 10/19/2015 |
10/19/2015 | Protalix BioTherapeutics, Inc. | PLX | Purchase | Common Stock | 4M | $1.00 | $4M | See Footnotes | 10/19/2015 |
10/19/2015 | Protalix BioTherapeutics, Inc. | PLX | Purchase | Common Stock | 423 | $1.03 | $435.7 | See Footnotes | 10/19/2015 |
10/19/2015 | Protalix BioTherapeutics, Inc. | PLX | Purchase | Common Stock | 4M | $1.00 | $4M | See Footnotes | 10/19/2015 |